Protect Loved Ones — Make EpiPens Available In Public Areas
433 signatures toward our 30,000 Goal
Sponsor: The Breast Cancer Site
Every moment matters – help call for Epinephrine in all public spaces to save lives and protect our communities from deadly allergic reactions.
Every year, millions of Americans face the threat of severe allergic reactions. Anaphylaxis strikes without warning, leading to life-threatening symptoms that demand immediate intervention. Epinephrine, commonly known as EpiPen, is the only effective treatment to reverse these reactions and save lives1.
The Current Gap in Epinephrine Availability
Despite its critical importance, epinephrine is not consistently available in all public spaces. Schools, restaurants, and commercial airlines often lack the necessary supplies to respond swiftly during an emergency. This gap can result in tragic outcomes, especially for those who depend on immediate access to EpiPens to survive2.
Legislative Progress and Challenges
Legislative efforts are underway to address this urgent need. Recent bills, such as those passed in New York, mandate that large public venues stock epinephrine auto-injectors and ensure trained personnel are present3. These measures are designed to protect individuals with severe allergies by providing immediate access to life-saving medication, regardless of where they are4.
However, challenges remain. The high cost of epinephrine auto-injectors poses a significant barrier to widespread accessibility5. Additionally, proper training is essential to ensure that epinephrine is administered correctly during emergencies. Without comprehensive training programs, the presence of EpiPens alone is insufficient to guarantee their effective use2.
One significant barrier to widespread epinephrine availability is cost, but there is also varibility in legislation across states, with some states fully reimbursing AAIs while others struggle with affordability issues. High costs can limit access, making it essential for policymakers to address pricing and insurance coverage to ensure that AAIs are accessible to all who need them.
The Path Forward: Advocacy and Policy Changes
Advocacy groups, including the American Academy of Allergy, Asthma & Immunology (AAFA), are pushing for standardized policies across all states. They emphasize the need for uniform legislation that requires all public buildings, including privately-owned restaurants, and commercial airline flights to carry EpiPens4. By doing so, we can create a safer environment for millions of Americans who live with severe allergies.
Act Now to Save Lives
Expanding access to epinephrine goes beyond saving individual lives. It fosters a more inclusive society where people with allergies can navigate public spaces without fear. Ensuring that EpiPens are readily available in all public venues not only protects those at risk but also provides peace of mind to their families and communities3.
The time to act is now. Every second counts during an anaphylactic reaction, and delayed treatment can have fatal consequences. By mandating the presence of epinephrine in all public spaces and commercial flights, we take a significant step toward preventing unnecessary tragedies and ensuring that help is always within reach1.
Join us in advocating for this life-saving measure. Your support can drive the necessary legislative changes to make epinephrine accessible everywhere. Together, we can build a future where everyone, regardless of their health condition, can enjoy public spaces safely and confidently.
Sign the petition today to ensure epinephrine is available wherever you go. Your action can save lives.
- Allergy & Asthma Network (2025), "What is Epinephrine?."
- Charles Szumski, Euractiv (23 June 2023), "Euractiv Adrenaline Auto-Injectors in Public Places Could Save Lives Experts Say."
- Molly Burke, Times Union (3 June 2024), "Bill Would Require EpiPens Training at Large Public Venues."
- Asthma and Allergy Foundation of America (2024), "Epinephrine in Schools and Public Places."
- The Original Allergy Emergency Kit™ (2025), "Epinephrine Legislation Sorted By State."
The Petition:
To the Deputy Secretary of the United States Department of Health and Human Services, the Commissioner of the U.S. Food and Drug Administration, and the U.S. Secretary of Transportation
We, the undersigned, urgently call upon your esteemed departments to implement a nationwide mandate ensuring that all public buildings, including privately-owned restaurants, and all commercial airline flights are equipped with epinephrine auto-injectors (EpiPens). This measure is critical to safeguarding the lives of millions of Americans who suffer from severe allergies and are at risk of anaphylactic reactions.
Anaphylaxis is a rapid and potentially fatal allergic reaction that can occur without warning. Immediate administration of epinephrine is the only effective treatment to reverse life-threatening symptoms such as airway constriction, severe swelling, and a drastic drop in blood pressure. Despite the availability of EpiPens, many public venues and modes of transportation lack the necessary preparedness to respond swiftly in emergencies. This gap in accessibility can lead to tragic outcomes, especially in high-risk environments where allergens are prevalent, such as restaurants and airplanes.
By mandating the presence of EpiPens in all public buildings and commercial flights, we can significantly reduce the risk of fatal anaphylactic reactions. This initiative will provide peace of mind to individuals with severe allergies, knowing that immediate medical intervention is readily available. Moreover, it underscores our collective commitment to public health and safety, fostering an inclusive environment where everyone can navigate public spaces and air travel with confidence.
We urge you to prioritize this essential public health measure and take decisive action to protect lives across our nation.
Sincerely,
